Pantoprazole Bristol Laboratories (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Erosive gastritis and duodenal ulcers: accelerates ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.
• Prevention of NSAID‑induced gastric ulcers: lowers the incidence of ulcer formation in patients requiring long‑term NSAID therapy.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to an increase in gastric pH and allowing damaged mucosa to heal.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea or abdominal discomfort.
• Flatulence or bloating.
• Constipation.
• Dry mouth.

Serious or Rare Side Effects

• Severe allergic reactions such as anaphylaxis or angioedema.
• Clostridioides difficile‑associated colitis.
• Low magnesium levels (hypomagnesemia) with prolonged use.
• Acute interstitial nephritis.
• Fracture risk with long‑term high‑dose therapy.
• Liver enzyme elevations indicating potential hepatic injury.

Before initiating therapy, consider the following precautions:

• Assess renal and hepatic function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor for signs of infection: especially Clostridioides difficile.
• Evaluate bone health: long‑term use may affect calcium absorption.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Antifungal agents such as ketoconazole or itraconazole: reduced absorption and efficacy.
• HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in anticoagulant effect.
• Methotrexate (high dose): possible elevation of serum levels.
• Digoxin: may increase serum concentration.
• Clopidogrel: reduced antiplatelet activity.
• Oral contraceptives: possible decrease in hormonal effectiveness.